Literature DB >> 2477110

Diabetic retinopathy.

E M Kohner.   

Abstract

Involvement of the retinal microvascular vessels is an almost inevitable consequence of long standing diabetes. In the only large scale epidemiology study of a Caucasian population Klein et al. found some degree of retinopathy in up to 97% of patients with insulin dependent diabetes mellitus (IDDM) after about 15 years diabetes duration and in about 60% of insulin treated patients of older onset, presumably non-insulin dependent diabetic patients (NIDDM). The presence of retinopathy does not indicate impending visual loss in all patients. Thus in IDDM the sight threatening forms of retinopathy is most commonly associated with neovascularization; up to 60% of patients develop this lesion after 20 years diabetes duration, while in the older age group new vessels are far less common. In clinic populations the commonest cause of visual loss in NIDDM is associated with macular oedema but in the population studies of Klein, prevalence of macular oedema was almost as common in IDDM as in NIDDM patients.

Entities:  

Mesh:

Year:  1989        PMID: 2477110     DOI: 10.1093/oxfordjournals.bmb.a072309

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  11 in total

1.  Blood pressure control and diabetic retinopathy.

Authors:  R Klein; B E K Klein
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells.

Authors:  W Li; X Liu; M Yanoff; S Cohen; X Ye
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

Review 3.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

4.  Glyceraldehyde-3-phosphate dehydrogenase in retinal microvasculature: implications for the development and progression of diabetic retinopathy.

Authors:  Sally Madsen-Bouterse; Ghulam Mohammad; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-29       Impact factor: 4.799

5.  Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.

Authors:  Renu A Kowluru; Mamta Kanwar
Journal:  Free Radic Biol Med       Date:  2009-04-05       Impact factor: 7.376

6.  Diabetes regulates small molecular weight G-protein, H-Ras, in the microvasculature of the retina: implication in the development of retinopathy.

Authors:  Mamta Kanwar; Renu A Kowluru
Journal:  Microvasc Res       Date:  2008-04-25       Impact factor: 3.514

7.  Impaired reduction of nocturnal systolic blood pressure and severity of diabetic retinopathy.

Authors:  João Soares Felício; Juliana Torres Pacheco; Sandra Roberta Ferreira; Frida Plavnik; Valdir Moisés; Oswaldo Kohlmann Junior; Artur Beltrame Ribeiro; Maria Tereza Zanella
Journal:  Exp Clin Cardiol       Date:  2007

8.  Association of systemic and ocular risk factors with neurosensory retinal detachment in diabetic macular edema: a case-control study.

Authors:  Aditi Gupta; Rajiv Raman; Vaitheeswaran Kulothungan; Tarun Sharma
Journal:  BMC Ophthalmol       Date:  2014-04-09       Impact factor: 2.209

9.  Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients.

Authors:  Anders Boeck Jensen; Pope L Moseley; Tudor I Oprea; Sabrina Gade Ellesøe; Robert Eriksson; Henriette Schmock; Peter Bjødstrup Jensen; Lars Juhl Jensen; Søren Brunak
Journal:  Nat Commun       Date:  2014-06-24       Impact factor: 14.919

10.  Risk factors for retinal microvascular impairment in type 2 diabetic patients without diabetic retinopathy.

Authors:  Dong-Hyun Lee; Ho Chul Yi; So Hyun Bae; Joon Hee Cho; Sang Wook Choi; Hakyoung Kim
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.